Impax gets FDA approval for generic Adderall XR

Impax Laboratories has received FDA approval for its Abbreviated New Drug Application to produce a generic version of Adderall XR. The drug will come in the form of an extended release capsule, in dosages of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg.

Read the source article at Pharmacy Choice